基础医学与临床 ›› 2007, Vol. 27 ›› Issue (12): 1324-1328.

• 研究论文 • 上一篇    下一篇

人sTNFR1真核表达载体构建及体外抑制TNFα细胞毒效应

傅蕾 彭仕芳 谭德明   

  1. 中南大学湘雅医院感染病科 中南大学湘雅医院感染病科 中南大学湘雅医院感染病科
  • 收稿日期:2007-01-16 修回日期:2007-05-29 出版日期:2007-12-25 发布日期:2007-12-25
  • 通讯作者: 傅蕾

Construction of eukaryotic recombinant sTNFR1 plasmid and its inhibitory effects on TNFαcytotoxicity in vitro

Lei FU, Shi-fang PENG, De-ming TAN   

  1. Department of infectious Diseases, Xiangya Hospital, Central South University
  • Received:2007-01-16 Revised:2007-05-29 Online:2007-12-25 Published:2007-12-25
  • Contact: Lei FU,

摘要: 目的 构建人可溶性肿瘤坏死因子受体1基因(sTNFR1)的真核表达载体,研究sTNFR1对TNFα细胞毒效应的抑制作用。方法 以Hela细胞的总RNA为模板,用RT-PCR方法扩增人sTNFR1全编码区基因片段,构建含有目的片段的T载体克隆及真核表达载体pcDNA3.1(-)重组质粒亚克隆,用脂质体法将重组质粒pcDNA3.1(-)-sTNFR1瞬时转染QSG7701细胞,半定量PT-PCR法检测sTNFR1mRNA的表达,MTT法检测sTNFR1对TNFα细胞毒效应的抑制作用。结果 人sTNFR1基因被正确克隆入真核表达载体pcDNA3.1(-);通过与3-磷酸甘油醛(GAPDH)比较, pcDNA3.1(-)-sTNFR1转染的QSG7701细胞中sTNFR1mRNA表达量明显高于空载体对照组和空细胞对照组(P<0.05); pcDNA3.1(-)- sTNFR1瞬时转染QSG7701细胞,TNFα对其细胞毒性作用受到抑制,当TNF-α浓度为100ng/mL时pcDNA3.1(-)-sTNFR1/QSG7701的细胞毒性较QSG7701下降64.8% 。结论 成功地构建真核表达质粒pcDNA3.1(-)-sTNFR1,TNFα对瞬时转染pcDNA3.1(-)- sTNFR1/QSG7701的细胞株细胞毒性作用受到抑制。

关键词: 人可溶性肿瘤病坏死因子受体1, 真核表达, 瞬时转染, 细胞毒性作用

Abstract: Objective To construct an eukaryotic expression vector of human sTNFR1 and investigate its inhibitory effects of the bioactivity of TNFα. Methods The total RNA was extracted from Hela cells and used as a template to amplify human sTNFR1 gene by reverse transcription polymerase chain reaction (RT-PCR). The PCR products were cloned into T vector and sub-cloned into vector pcDNA3.1(-), an eukaryotic expression vector. The recombinant plasmid pcDNA3.1(-)-sTNFR1 was transfected into QSG7701 cells by using lipofectamine ,RT-PCR was performed to detect the expression of sTNFR1, MTT was used to observe sTNFR1 gene 's inhibitory effect on TNFα.Results The exactitude of recombinant vector pCDNA3.1(-)-sTNFR1 was identified by digestion and DNA sequencing analysis, After being trancfected pcDNA3.1(-)-sTNFR1, QSG7701 had higer expression level of sTNFR1mRNA than the pcDNA3.1(-) trancfected control; After the recombinant plasmid pcDNA3.1(-)-sTNFR1 was transfected into QSG7701 cell transiently. The cytotoxic effect of TNFα was inhibited to the extent of 64.8% when its concentration was 100ng/mL. Conclusion We constructed the eukaryotic expression vector containing Human sTNFR1 gene successfully, the cytotoxicity of TNFαcan be inhibited in pcDNA3.1(-)- sTNFR1/QSG7701 cells.

Key words: human sTNFR1, eukaryotic expression, transiently transfection, cytotoxicity